Back to Podcast
Midday Wave #116 Bearish

Midday Wave #116: Breadth Screams: Reading a Dark Tape Into the Close – Thursday 9/24/2026

September 24, 2026 5:10
Episode Summary
With SPY, QQQ, and IWM data unavailable, the hosts lean on breadth internals to read the market — finding a stable long-term bearish regime but a sharp short-term breakdown in participation. Single-name flow shows narrow leadership, volume-starved continuation trades, and one standout momentum print in SVRN, prompting a tighter, confirmation-first posture into the close.
Key Takeaways
  • 20SMA breadth collapsed to 28% from 82% yesterday
  • 40SMA breadth flat at 20.71%, still oversold and bearish
  • Continuation signals lack volume — most print sub-1.0 RVOL
  • SIP flow dominated by downgrades and drug-trial misses
  • Tech is the lone relative-strength sector at 97th percentile
0:00 / 5:10

Midday Situation Check

Bearish regime intact — 40SMA breadth at 20.71% (essentially flat from 20.67% yesterday), while 20SMA breadth collapsed to 28% from 82% (-54pp), a sharp intraday deterioration in short-term participation.

Market Recap — Session So Far

Index tape is dark at midday, so we lean on internals — and the internals are flashing caution as 20-day breadth caves.

  • SPY, QQQ, and IWM data is unavailable for this session — no confirmed index levels or SMA references to cite, so we’re trading the breadth and single-name picture only.
  • Breadth momentum is negative: Bull 4% dropped to 64 from 88 yesterday, and Bear 4% fell to 143 from 344 — fewer new signals on both sides, but the 20SMA breadth crash to 28% is the headline.
  • Sentiment reads Bearish on 4% and Oversold on the 40SMA — the same oversold backdrop as yesterday, but no thrust yet to relieve it.

Momentum Watch — Breakout Continuation & SIP

  • Strongest continuation reads are defensive-tech and medical: ARQQ +3.1% at $23.24 (but RVOL just 0.1 — no conviction), A +2.9% at $170.18 (RVOL 0.8, MEDICAL/INST), and CLS +2.6% at $371.28 (RVOL 0.6, INST).
  • New SIP entry of note: RCL at $230.35 on a JP Morgan price-target raise (Revenue tag, LEISURE) — but it’s down 2.1% from the open despite RVOL of 3.29, a bullish note fading intraday.
  • Follow-through is thin — nearly every continuation name is printing sub-1.0 RVOL (DDOG RVOL 0.3, AMD 0.8, MTSI 0.3), so breakouts lack the volume to trust in this tape.

Strategy Check — Continuation, SIP & 20% Study

  • Continuation leader holding since open: A +2.9% ($170.18, RVOL 0.8, MEDICAL/INST) and CLS +2.6% ($371.28, RVOL 0.6, ELECTRNCS/INST) are the cleanest institutional-backed names; MTSI -1.1% and FTEC -0.5% are the fades to avoid.
  • SIP movers skew negative: UTHR -2.1% ($489.42) on a Goldman Sell initiation, ACAD -3.71% ($25.43) after a drug missed its primary endpoint, and CGEM -22.15% ($16.87, RVOL 2.82) gutted on pipeline milestones — negative catalysts dominating the flow.
  • 20% Study is almost entirely ETF/ETN noise (AMAU, CONX, COIW, CLSX, MSTW) with weak participation; the one single-name standout is SVRN ($32.55, crypto/finance) with RVOL 3.96 and a 26.66 ATR-multiple thrust — a speculative outlier, not a broad institutional confirmation.

Quick Takes & Wrap-Up

  • A — watch $170.18 as the pivot; holding above with RVOL improving keeps the medical-momentum continuation alive into the afternoon.
  • RCL — down 2.1% from open despite the JPM upgrade; a reclaim of the $230.35 area on RVOL 3.29 would flip the fade back bullish.
  • Overall bias: defensive. With 20SMA breadth cratering to 28% and 40SMA stuck at 20.71% oversold, this is an Always-Be-in-Control (ABC) and Controlled-Risk-Taking (CRT) tape — keep size small, respect stops, and let volume confirm before chasing.

Sector note: Technology (RSPT) sits at the 97th percentile and is the lone relative-strength pocket, while Consumer Discretionary (RSPD -2.22, 0th pct), Financials (RSPF -2.16, 0th pct), and Industrials (RSPN -2.15) are pinned at the bottom — leadership is narrow and rotational, not broad.

Share:

Find momentum stocks in milliseconds

Try WaveFinder